Global PEGylated Proteins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global PEGylated Proteins Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
PEGylated Proteins report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PEGylated Proteins market is projected to reach US$ 4908.6 million in 2034, increasing from US$ 3769 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2034. Demand from Cancer Treatment and Hepatitis are the major drivers for the industry.
The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PEGylated Proteins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
Segment by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibodies
Others
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the PEGylated Proteins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PEGylated Proteins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PEGylated Proteins industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PEGylated Proteins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PEGylated Proteins introduction, etc. PEGylated Proteins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of PEGylated Proteins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
PEGylated Proteins report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PEGylated Proteins market is projected to reach US$ 4908.6 million in 2034, increasing from US$ 3769 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2034. Demand from Cancer Treatment and Hepatitis are the major drivers for the industry.
The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PEGylated Proteins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
Segment by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibodies
Others
Segment by Application
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the PEGylated Proteins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PEGylated Proteins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PEGylated Proteins industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PEGylated Proteins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PEGylated Proteins introduction, etc. PEGylated Proteins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of PEGylated Proteins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices